Myriad Genetics Inc (MYGN)
18.18
+0.20
(+1.11%)
USD |
NASDAQ |
Apr 26, 16:00
18.18
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Cash and Short Term Investments (Quarterly): 140.90M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 140.90M |
| September 30, 2023 | 86.30M |
| June 30, 2023 | 121.60M |
| March 31, 2023 | 78.70M |
| December 31, 2022 | 114.90M |
| September 30, 2022 | 193.20M |
| June 30, 2022 | 205.10M |
| March 31, 2022 | 268.40M |
| December 31, 2021 | 338.80M |
| September 30, 2021 | 366.10M |
| June 30, 2021 | 164.40M |
| March 31, 2021 | 176.10M |
| September 30, 2020 | 160.40M |
| June 30, 2020 | 217.80M |
| March 31, 2020 | 181.50M |
| December 31, 2019 | 141.60M |
| September 30, 2019 | 142.60M |
| June 30, 2019 | 136.90M |
| March 31, 2019 | 149.70M |
| December 31, 2018 | 165.40M |
| September 30, 2018 | 167.50M |
| June 30, 2018 | 180.60M |
| March 31, 2018 | 157.30M |
| December 31, 2017 | 143.50M |
| September 30, 2017 | 148.30M |
| Date | Value |
|---|---|
| June 30, 2017 | 150.70M |
| March 31, 2017 | 172.10M |
| December 31, 2016 | 162.50M |
| September 30, 2016 | 148.40M |
| June 30, 2016 | 159.00M |
| March 31, 2016 | 216.70M |
| December 31, 2015 | 219.30M |
| September 30, 2015 | 155.40M |
| June 30, 2015 | 144.80M |
| March 31, 2015 | 134.43M |
| December 31, 2014 | 165.12M |
| September 30, 2014 | 159.61M |
| June 30, 2014 | 186.40M |
| March 31, 2014 | 212.16M |
| December 31, 2013 | 353.60M |
| September 30, 2013 | 357.02M |
| June 30, 2013 | 372.32M |
| March 31, 2013 | 336.16M |
| December 31, 2012 | 358.63M |
| September 30, 2012 | 349.16M |
| June 30, 2012 | 340.53M |
| March 31, 2012 | 337.36M |
| December 31, 2011 | 350.63M |
| September 30, 2011 | 349.52M |
| June 30, 2011 | 346.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
78.70M
Minimum
Mar 2023
366.10M
Maximum
Sep 2021
179.74M
Average
162.40M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Stryker Corp | 3.053B |
| Perspective Therapeutics Inc | 9.238M |
| Electromed Inc | 10.43M |
| Xtant Medical Holdings Inc | 5.715M |
| Asensus Surgical Inc | 21.07M |